Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
364-03-004 ISMRM Abstract

Assessment of the Disease Activity in Patients with Graves’ Ophthalmopathy with TSE-DWI and EPI-DWI

Primary: Diffusion - Diffusion Acquisition
Secondary: Musculoskeletal - Muscle
364-03-004 · Diffusion MRI Applications in Disease · Monday, 11 May, 1:50 PM–2:45 PM · Digital Posters Row E
Keywords: Diffusion-Weighted Imaging Graves ophthalmopathy Turbo spin-echo DWI
Accepted
miaomiao ding 1, Wenshi Chen1, Yue Xie1, Xiaohong Chen1, Weifeng Su1, Jun Peng2, Yun Su1, xiang liu1
1Department of Radiology, Sun Yat-Sen University Sun Yat-Sen Memorial Hospital, Guangzhou, China
2Department of Clinical & Technical Solutions, Philips Healthcare, Guangzhou, China
Presenting Author: miaomiao ding

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Rose GE. Clinical activity score as a guide in the management of patients with Graves' orbitopathy. Clin Endocrinol (Oxf). 1997;47(1):15.
2. Subekti I, Soewondo P, Soebardi S, Darmowidjojo B, Harbuwono DS, Purnamasari D, et al. Practical Guidelines Management of Graves Ophthalmopathy. Acta Med Indones. 2019;51(4):364-71.
3. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, et al. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016;5(1):9-26.
4. Heverhagen JT. Noise measurement and estimation in MR imaging experiments. Radiology. 2007;245(3):638-9.
5. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73(8):639-44.
6. Luccas R, Riguetto CM, Alves M, Zantut-Wittmann DE, Reis F. Computed tomography and magnetic resonance imaging approaches to Graves' ophthalmopathy: a narrative review. Front Endocrinol (Lausanne). 2023;14:1277961.
7. Cheng J, Zhang X, Lian J, Piao Z, Zhou L, Gou X, et al. Evaluation of activity of Graves' orbitopathy with multiparameter orbital magnetic resonance imaging (MRI). Quant Imaging Med Surg. 2023;13(5):3040-9.
8. Kilicarslan R, Alkan A, Ilhan MM, Yetis H, Aralasmak A, Tasan E. Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease. Br J Radiol. 2015;88(1047):20140677.
9. Liu X, Su Y, Jiang M, Fang S, Huang Y, Li Y, et al. Application of Magnetic Resonance Imaging in the Evaluation of Disease Activity in Graves' Ophthalmopathy. Endocr Pract. 2021;27(3):198-205.
10. Politi LS, Godi C, Cammarata G, Ambrosi A, Iadanza A, Lanzi R, et al. Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg. Eur Radiol. 2014;24(5):1118-26.
11. Razek AA, El-Hadidy EM, Moawad ME, El-Metwaly N, El-Said AAE. Assessment of lacrimal glands in thyroid eye disease with diffusion-weighted magnetic resonance imaging. Pol J Radiol. 2019;84:e142-e6.
12. Verhappen MH, Pouwels PJ, Ljumanovic R, van der Putten L, Knol DL, De Bree R, et al. Diffusion-weighted MR imaging in head and neck cancer: comparison between half-fourier acquired single-shot turbo spin-echo and EPI techniques. AJNR Am J Neuroradiol. 2012;33(7):1239-46.
13. Lingam RK, Mundada P, Lee V. Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave's orbitopathy: An initial observational cohort study. Orbit. 2018;37(5):325-30.
14. Khant ZA, Azuma M, Kadota Y, Hattori Y, Takeshima H, Yokogami K, et al. Evaluation of pituitary structures and lesions with turbo spin-echo diffusion-weighted imaging. J Neurol Sci. 2019;405:116390.
15. Yoshizako T, Yoshida R, Asou H, Nakamura M, Kitagaki H. Comparison between turbo spin-echo and echo planar diffusion-weighted imaging of the female pelvis with 3T MRI. Acta Radiol Open. 2021;10(2):2058460121994737.
16. Wiesmueller M, Wuest W, May MS, Ellmann S, Heiss R, Saake M, et al. Comparison of Readout-Segmented Echo-Planar Imaging and Single-Shot TSE DWI for Cholesteatoma Diagnostics. AJNR Am J Neuroradiol. 2021;42(7):1305-12.
17. Hirata K, Nakaura T, Okuaki T, Kidoh M, Oda S, Utsunomiya D, et al. Comparison of the image quality of turbo spin echo- and echo-planar diffusion-weighted images of the oral cavity. Medicine (Baltimore). 2018;97(19):e0447.
18. Hiwatashi A, Togao O, Yamashita K, Kikuchi K, Kamei R, Yoshikawa H, et al. Diffusivity of intraorbital lymphoma vs. inflammation: comparison of single shot turbo spin echo and multishot echo planar imaging techniques. Eur Radiol. 2018;28(1):325-30.
19. Dosiou C, Kossler AL. Thyroid Eye Disease: Navigating the New Treatment Landscape. J Endocr Soc. 2021;5(5):bvab034.
20. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf). 1997;47(1):9-14.
21. Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol. 2006;155(3):387-9.
22. Mikayama R, Yabuuchi H, Sonoda S, Kobayashi K, Nagatomo K, Kimura M, et al. Comparison of intravoxel incoherent motion diffusion-weighted imaging between turbo spin-echo and echo-planar imaging of the head and neck. Eur Radiol. 2018;28(1):316-24.
23. Moon WJ. Measurement of signal-to-noise ratio in MR imaging with sensitivity encoding. Radiology. 2007;243(3):908-9.
24. Panyarak W, Chikui T, Yamashita Y, Kamitani T, Yoshiura K. Image Quality and ADC Assessment in Turbo Spin-Echo and Echo-Planar Diffusion-Weighted MR Imaging of Tumors of the Head and Neck. Acad Radiol. 2019;26(10):e305-e16.
25. He G, Dunn HP, Ahmad KE, Watson E, Henderson A, Tynan D, et al. Fundoscopy use in neurology departments and the utility of smartphone photography: a prospective prevalence and crossover diagnostic accuracy study amongst neurology inpatients. Eur J Neurol. 2022;29(8):2463-72.
26. Kundel HL, Polansky M. Measurement of observer agreement. Radiology. 2003;228(2):303-8.
27. Takatsu Y, Nakamura M, Sagawa H, Suzuki Y, Mori N, Motegi S, et al. Differences in apparent diffusion coefficients between normal brain echo-planar images and turbo spin-echo diffusion-weighted images with distortion correction. Eur J Radiol. 2022;149:110202.
28. Wan Q, Lei Q, Wang P, Hu J, Zhang T, Yu D, et al. Intravoxel Incoherent Motion Diffusion-Weighted Imaging of Lung Cancer: Comparison Between Turbo Spin-Echo and Echo-Planar Imaging. J Comput Assist Tomogr. 2020;44(3):334-40.
29. Khemani S, Singh A, Lingam RK, Kalan A. Imaging of postoperative middle ear cholesteatoma. Clin Radiol. 2011;66(8):760-7.
30. Han Z, Huang Y, Xie J, Liu Y, Gong S, Yang Z, et al. Comparative analysis of vestibular endolymphatic hydrops grading methods and hearing loss in Ménière's disease: a retrospective MRI study using 3D-real inversion recovery sequence. Eur Arch Otorhinolaryngol. 2024;281(9):4585-92.
31. Han JS, Seo HS, Lee YH, Lee H, Suh SI, Jeong EK, et al. Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy. Neuroradiology. 2016;58(12):1189-96.
32. Zhang H, Wang C, Chen W, Wang F, Yang Z, Xu S, et al. Deep learning based multiplexed sensitivity-encoding (DL-MUSE) for high-resolution multi-shot DWI. Neuroimage. 2021;244:118632.
33. Wang Y, Cui Y, Dai J, Ni S, Zhang T, Chen X, et al. Prospective Comparison of FOCUS MUSE and Single-Shot Echo-Planar Imaging for Diffusion-Weighted Imaging in Evaluating Thyroid-Associated Ophthalmopathy. Korean J Radiol. 2024;25(10):913-23.
34. Hu H, Chen L, Zhou J, Chen W, Chen HH, Zhang JL, et al. Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging. Eur J Radiol. 2022;151:110295.
35. Abdel Razek AA, El-Hadidy M, Moawad ME, El-Metwaly N, El-Said AA. Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy. Neuroradiol J. 2017;30(3):230-4.
36. Tachibana S, Murakami T, Noguchi H, Noguchi Y, Nakashima A, Ohyabu Y, et al. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy. Endocr J. 2010;57(10):853-61.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/364-03-004